Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-08-29

Clinical Trial Update: Hypoglycemic Effects of Fermented Red Ginseng in Subject With Impaired Fasting Glucose or Type 2 Diabetes [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 study evaluating the hypoglycemic effects of fermented red ginseng in individuals with impaired fasting glucose or Type 2 diabetes, now completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fermented-Red Ginseng (Panax ginseng)

Snippet

Sponsor: Chonbuk National University Hospital | Conditions: Impaired Glucose or Type 2 Diabetes | Phase 2, Phase 3 | Status: COMPLETED